Guideline of guidelines: non-muscle-invasive bladder cancer

Solomon L. Woldu, Aditya Bagrodia, Yair Lotan

Research output: Contribution to journalArticle

61 Scopus citations

Abstract

Non-muscle-invasive bladder cancer (NMIBC) represents the vast majority of bladder cancer diagnoses, but this definition represents a spectrum of disease with a variable clinical course, notable for significant risk of recurrence and potential for progression. Management involves risk-adapted strategies of cystoscopic surveillance and intravesical therapy with the goal of bladder preservation when safe to do so. Multiple organizational guidelines exist to help practitioners manage this complicated disease process, but adherence to management principles among practising urologists is reportedly low. We review four major organizational guidelines on NMIBC: the American Urological Association (AUA)/Society of Urologic Oncology (SUO), European Association of Urology (EAU), National Comprehensive Cancer Network (NCCN), and National Institute for Health and Care Excellence (NICE) guidelines.

Original languageEnglish (US)
Pages (from-to)371-380
Number of pages10
JournalBJU International
Volume119
Issue number3
DOIs
Publication statusPublished - Mar 1 2017

    Fingerprint

Keywords

  • #BladderCancer
  • #blcsm
  • guidelines
  • management
  • non-muscle-invasive bladder cancer

ASJC Scopus subject areas

  • Urology

Cite this